Yatharth Hospital declares ₹0.50 interim dividend, approves Q1 FY27 results & ESOP 2026
Yatharth Hospital declared an interim dividend of ₹0.50 per share for FY26-27. The company approved Q1 FY27 results, with consolidated revenue at ₹3,926.54 million and standalone revenue at ₹1,763.08 million. The Board also approved the ESOP 2026 scheme covering 2.5 lakh shares, subject to shareholder nod.
The interim dividend declaration and approval of quarterly results have a moderate impact on investor sentiment and stock performance. The introduction of an ESOP scheme is also a significant development.
The declaration of an interim dividend and approval of financial results are generally positive indicators for the company.
Yatharth Hospital & Trauma Care Services Limited announced the outcome of its Board Meeting held on August 10, 2026. The Board approved the unaudited financial results for the first quarter ended June 30, 2026, both on a standalone and consolidated basis.
Additionally, the company declared its first interim dividend for the Financial Year 2026-27 at a rate of ₹0.50 per equity share of face value ₹10 each. The total payout amounts to ₹4,81,77,178.50. The record date for determining entitlement to this interim dividend has been fixed as Friday, August 14, 2026.
The Board also approved the introduction of the “Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme - 2026” (ESOP 2026), subject to shareholder approval. This scheme covers 2,50,000 equity shares. The company further re-appointed M/s Subodh Kumar & Co. as the Cost Auditor for the Financial Year 2026-27.
The Board meeting commenced at 02:33 PM and concluded at 03:41 PM IST. The company also reported a consolidated revenue from operations of ₹3,926.54 million for the quarter ended June 30, 2026, and a profit after tax of ₹454.23 million attributable to owners of the holding company. Standalone revenue from operations was ₹1,763.08 million with a profit after tax of ₹281.68 million.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.